Global Direct-To-Consumer Genetic Testing Market to exceed US $2.5 Bn by 2025

February 21, 2020


According to the latest research report titled ‘Direct-to-Consumer Genetic Testing Market Size By Test Type (Carrier Testing, Predictive Testing, Ancestry & Relationship Testing, Nutrigenomics Testing), By Technology (Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, South Korea, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Potential, Competitive Market Share & Forecast, 2019 – 2025’ available at MarketStudyReport.com, the global direct-to-consumer (DTC) genetic testing market is anticipated to cross US $2.5 billion by the year 2025.
 

Substantial growth in the number of people diagnosed with genetic diseases like thalassemia, hemophilia, sickle cell anemia, Tay Sachs disease, Huntington's disease, and cystic fibrosis will provide the key growth impetus to direct-to-consumer (DTC) genetic testing market. As per the data of WHO, approximately 72,000 people across the United States are suffer from sickle cell anemia annually. This factor, coupled with rising consumer inclination towards accessing detailed genetic information will propel the demand for DTC genetic testing kits. Upsurge in the global economy, along with improving healthcare expenditure are aiding the market expansion.
 

Based on test type, ancestry & relationship testing segment is slated to observe substantial growth over the coming years owing to the accurate and detailed data offered by these tests about the ethnic background of a person. Recently launched ancestry DTC tests help to link the ancestry genetic testing and health-related genetic testing. Considering these factors, the segment will observe a growth of about 13% through 2025, cites the report. 
   

As per the study, North America DTC genetic testing industry is predicted to witness a growth of approximately 14% over the forecast timeframe. Suitable regulatory norms regarding DTC genetic tests are likely to foster the growth of direct-to-consumer genetic testing market in North America. Regulatory bodies like FDA have defined laws that ensure the availability of high-quality DTC genetic tests. In addition, increasing consumer preference for personalized medicines across the United States and Canada will augment the regional market share.
 

Request sample copy of this Report@  https://www.marketstudyreport.com/request-a-sample/1434129/
 

The list of prominent direct-to-consumer genetic testing industry players includes companies like Pathway Genomics, Living DNA, MyHeritage, Karmagenes, Genesis HealthCare, Identigene, Helix, EasyDNA, Family Tree DNA, MapMyGenome, Color, Ancestry, 23andMe, and Full Genomes.


Frequently Asked Questions (FAQ) :

Substantial growth in the number of people diagnosed with genetic diseases like thalassemia, hemophilia, sickle cell anemia, Tay Sachs disease, Huntington's disease, and cystic fibrosis will provide the key growth impetus to global direct-to-consumer (DTC) genetic testing market. As per the data of WHO, approximately 72,000 people across the United States are suffer from sickle cell anemia annually. This factor, coupled with rising consumer inclination towards accessing detailed genetic information will propel the demand for DTC genetic testing kits. Upsurge in the global economy, along with improving healthcare expenditure are aiding the market expansion.
Based on test type, ancestry & relationship testing segment is slated to observe substantial growth over the coming years owing to the accurate and detailed data offered by these tests about the ethnic background of a person. Recently launched ancestry DTC tests help to link the ancestry genetic testing and health-related genetic testing. Considering these factors, the segment will observe a growth of about 13% through 2025.
As per the study, North America DTC genetic testing industry is predicted to witness a growth of approximately 14% over the forecast timeframe. Suitable regulatory norms regarding DTC genetic tests are likely to foster the growth of direct-to-consumer genetic testing market in North America. Regulatory bodies like FDA have defined laws that ensure the availability of high-quality DTC genetic tests. In addition, increasing consumer preference for personalized medicines across the United States and Canada will augment the regional market share.
The list of prominent direct-to-consumer genetic testing industry players includes companies like Pathway Genomics, Living DNA, MyHeritage, Karmagenes, Genesis HealthCare, Identigene, Helix, EasyDNA, Family Tree DNA, MapMyGenome, Color, Ancestry, 23andMe, and Full Genomes.